Alastair Goldfisher

The firm is seeking to raise $100m for its debut fund, according to regulatory filings, and has already raised about $71m from current and former execs of various tech and consumer companies.

Abzena has raised $10m in growth capital from Biospring Partners, a New York firm launched this year by Michelle Dipp and Jennifer Lum.

The former Microsoft executive co-founded the early-stage software firm Merus Capital in 2007. He was 51.

Fuse Venture Partners, which is targeting $100m for its debut fund, has raised nearly $71m in consolidated commitments so far.

Menlo Ventures, which raised $450m for its last main fund in 2017, is looking to raise the same amount for Fund XV to invest in early-stage companies.

Early-stage investor Threshold Ventures, formerly known as DFJ, has raised more than $146m from 20 investors for a fund targeting $250m.

In recent years, several venture firms, including CRV, have increased their focus on the bio sector. Here's why we're seeing it grow.

The machine-learning company reportedly secured millions from investors in recent years despite allegedly making false claims about its revenue and creating a made-up list of customers to include Fortune 500 companies.

The firm was founded by former NEA GP Kittu Kolluri in 2017 and raised $113.5m for its debut fund.

First-timer fund managers are having a tough time in the US, while megafunds are raking it in.